Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Carbonate | HCID 10340 | — |
| Reactant | 7-Chloro-3-(2,2,2-trifluoroacetyl)-6-trifluoromethylsulfonyloxy-2,3,4,5-tetrahydro-1H-benzo[d]azepine | HCID 57447747 | — |
| Reactant | HCID 59787429 | HCID 59787429 | — |
| Catalyst | HCID 178418476 | HCID 178418476 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Solvent | Oxolane--water (1/1) | HCID 21881883 | — |
| Product | HCID 86622788 | HCID 86622788 | — |
Reaction Steps
Dissolve 7-chloro-3-(2,2,2-trifluoroacetyl)-6-trifluoromethanesulfonyloxy-2,3,4,5-tetrahydro-1H-benzo[d]azepine (425 mg, 1 mmol), bis(triphenylphosphine)-palladium(II) chloride (0.1 equiv.), 3-[(2,2,2-trifluoroethyl-amino)-methyl]-phenyl-boronic acid (465 mg, 2.0 mmol) and sodium carbonate (2 equiv.) in THF/water (2:1, 15 mL) and heat the mixture at 80° C. for 6 h. Cool the reaction mixture to ambient temperature, dilute with EtOAc and wash with water. Dry the organic fraction over MgSO4, filter and concentrate in vacuo to obtain 7-chloro-3-(2,2,2-trifluoroacetyl)-6-{3-[(2,2,2-trifluoroethyl-amino)-methyl]-phenyl}-2,3,4,5-tetrahydro-1H-benzo[d]azepine, suitable for use without further purification.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08420631B2 |
|---|
| Source dataset | uspto-grants-2013_04 |
|---|
| ORD ID | ord-445f7cdb9c2f4df4b20a3307e7cb08f3 |
|---|
| Source note | uspto-grants-2013_04 |
|---|